Detalles de la búsqueda
1.
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.
Lancet Oncol
; 23(11): 1430-1440, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36244398
2.
Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study.
Oncologist
; 27(11): 905-e848, 2022 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36156099
3.
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels.
Ann Surg Oncol
; 2022 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34988836
4.
Novel Application of Iterative Hyperthermic Intraperitoneal Chemotherapy for Unresectable Peritoneal Metastases from High-Grade Appendiceal Ex-Goblet Adenocarcinoma.
Ann Surg Oncol
; 28(3): 1777-1785, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32892267
5.
Cytoreductive Surgery for Selected Patients Whose Metastatic Gastric Cancer was Treated with Systemic Chemotherapy.
Ann Surg Oncol
; 28(8): 4433-4443, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33420565
6.
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
; 21(8): 1066-1076, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32653053
7.
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
Cancer
; 125(10): 1629-1636, 2019 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30645764
8.
Initial Report of Second-Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi-Institutional Retrospective Analysis.
Oncologist
; 24(4): 475-482, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30470690
9.
FGFR2-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape.
Oncologist
; 24(11): 1462-1468, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31249137
10.
Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution.
Proc Natl Acad Sci U S A
; 112(47): E6496-505, 2015 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26561581
11.
Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 18(11): 1467-1482, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28958504
12.
MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
Cancer
; 123(6): 1061-1070, 2017 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27926778
13.
ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels.
Ann Surg Oncol
; 29(Suppl 3): 616-617, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35930113
14.
A subgroup cluster-based Bayesian adaptive design for precision medicine.
Biometrics
; 73(2): 367-377, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27775814
15.
Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.
Gastroenterology
; 149(7): 1794-1803.e4, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341722
16.
A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers.
Invest New Drugs
; 34(3): 319-28, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26994014
17.
Therapeutically Induced Changes in HER2, HER3, and EGFR Protein Expression for Treatment Guidance.
J Natl Compr Canc Netw
; 14(5): 503-7, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27160229
18.
Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH.
Gastric Cancer
; 19(4): 1066-1079, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26581548
19.
Tumor genome analysis includes germline genome: are we ready for surprises?
Int J Cancer
; 136(7): 1559-67, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25123297
20.
New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
Oncologist
; 19(3): 235-42, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24563076